Global Rare Disease Drug Market Professional Survey Report 2018

June 2018 | 129 pages | ID: GCCDFADE212EN
QYResearch

Abstracts

This report studies the global Rare Disease Drug market status and forecast, categorizes the global Rare Disease Drug market size (value & volume) by manufacturers, type, application, and region.
This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Rare Disease Drug market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

The regional scope of the study is as follows:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• >1‰
• 0.65‰～1‰
• <0.1‰

By Application, the market can be split into

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

The study objectives of this report are:

• To analyze and study the global Rare Disease Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key Rare Disease Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Rare Disease Drug are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Rare Disease Drug Manufacturers
Rare Disease Drug Distributors/Traders/Wholesalers
Rare Disease Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Rare Disease Drug market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Rare Disease Drug Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF RARE DISEASE DRUG

1.1 Definition and Specifications of Rare Disease Drug
  1.1.1 Definition of Rare Disease Drug
  1.1.2 Specifications of Rare Disease Drug
1.2 Classification of Rare Disease Drug
  1.2.1 >1‰
  1.2.2 0.65‰～1‰
  1.2.3 <0.1‰
1.3 Applications of Rare Disease Drug
  1.3.1 Hospital Pharmacies
  1.3.2 Speciality Pharmacies
  1.3.3 Retail pharmacies
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RARE DISEASE DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Rare Disease Drug
2.3 Manufacturing Process Analysis of Rare Disease Drug
2.4 Industry Chain Structure of Rare Disease Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RARE DISEASE DRUG

3.1 Capacity and Commercial Production Date of Global Rare Disease Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Rare Disease Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Rare Disease Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Rare Disease Drug Major Manufacturers in 2017

4 GLOBAL RARE DISEASE DRUG OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Rare Disease Drug Capacity and Growth Rate Analysis
  4.2.2 2017 Rare Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Rare Disease Drug Sales and Growth Rate Analysis
  4.3.2 2017 Rare Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Rare Disease Drug Sales Price
  4.4.2 2017 Rare Disease Drug Sales Price Analysis (Company Segment)

5 RARE DISEASE DRUG REGIONAL MARKET ANALYSIS

5.1 North America Rare Disease Drug Market Analysis
  5.1.1 North America Rare Disease Drug Market Overview
  5.1.2 North America 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Rare Disease Drug Sales Price Analysis
  5.1.4 North America 2017 Rare Disease Drug Market Share Analysis
5.2 Europe Rare Disease Drug Market Analysis
  5.2.1 Europe Rare Disease Drug Market Overview
  5.2.2 Europe 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Rare Disease Drug Sales Price Analysis
  5.2.4 Europe 2017 Rare Disease Drug Market Share Analysis
5.3 China Rare Disease Drug Market Analysis
  5.3.1 China Rare Disease Drug Market Overview
  5.3.2 China 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Rare Disease Drug Sales Price Analysis
  5.3.4 China 2017 Rare Disease Drug Market Share Analysis
5.4 Japan Rare Disease Drug Market Analysis
  5.4.1 Japan Rare Disease Drug Market Overview
  5.4.2 Japan 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Rare Disease Drug Sales Price Analysis
  5.4.4 Japan 2017 Rare Disease Drug Market Share Analysis
5.5 Southeast Asia Rare Disease Drug Market Analysis
  5.5.1 Southeast Asia Rare Disease Drug Market Overview
  5.5.2 Southeast Asia 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Rare Disease Drug Sales Price Analysis
  5.5.4 Southeast Asia 2017 Rare Disease Drug Market Share Analysis
5.6 India Rare Disease Drug Market Analysis
  5.6.1 India Rare Disease Drug Market Overview
  5.6.2 India 2013-2018E Rare Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Rare Disease Drug Sales Price Analysis
  5.6.4 India 2017 Rare Disease Drug Market Share Analysis

6 GLOBAL 2013-2018E RARE DISEASE DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Rare Disease Drug Sales by Type
6.2 Different Types of Rare Disease Drug Product Interview Price Analysis
6.3 Different Types of Rare Disease Drug Product Driving Factors Analysis
  6.3.1 >1‰ of Rare Disease Drug Growth Driving Factor Analysis
  6.3.2 0.65‰～1‰ of Rare Disease Drug Growth Driving Factor Analysis
  6.3.3 <0.1‰ of Rare Disease Drug Growth Driving Factor Analysis

7 GLOBAL 2013-2018E RARE DISEASE DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Rare Disease Drug Consumption by Application
7.2 Different Application of Rare Disease Drug Product Interview Price Analysis
7.3 Different Application of Rare Disease Drug Product Driving Factors Analysis
  7.3.1 Hospital Pharmacies of Rare Disease Drug Growth Driving Factor Analysis
  7.3.2 Speciality Pharmacies of Rare Disease Drug Growth Driving Factor Analysis
  7.3.3 Retail pharmacies of Rare Disease Drug Growth Driving Factor Analysis
  7.3.4 Others of Rare Disease Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RARE DISEASE DRUG

8.1 Novartis AG
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Novartis AG 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novartis AG 2017 Rare Disease Drug Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bristol-Myers Squibb Company 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bristol-Myers Squibb Company 2017 Rare Disease Drug Business Region Distribution Analysis
8.3 Celgene Corporation
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Celgene Corporation 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Celgene Corporation 2017 Rare Disease Drug Business Region Distribution Analysis
8.4 F. Hoffmann-La Roche Ltd.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 F. Hoffmann-La Roche Ltd. 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 F. Hoffmann-La Roche Ltd. 2017 Rare Disease Drug Business Region Distribution Analysis
8.5 Pfizer, Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Pfizer, Inc. 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Pfizer, Inc. 2017 Rare Disease Drug Business Region Distribution Analysis
8.6 Sanofi S.A.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi S.A. 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi S.A. 2017 Rare Disease Drug Business Region Distribution Analysis
8.7 Alexion Pharmaceuticals, Inc.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Alexion Pharmaceuticals, Inc. 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Alexion Pharmaceuticals, Inc. 2017 Rare Disease Drug Business Region Distribution Analysis
8.8 Eli Lilly and Company
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Eli Lilly and Company 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Eli Lilly and Company 2017 Rare Disease Drug Business Region Distribution Analysis
8.9 Novo Nordisk A/S
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Novo Nordisk A/S 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Novo Nordisk A/S 2017 Rare Disease Drug Business Region Distribution Analysis
8.10 AstraZeneca
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 AstraZeneca 2017 Rare Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 AstraZeneca 2017 Rare Disease Drug Business Region Distribution Analysis
8.11 Eisai Co., Ltd.
8.12 Daiichi Sankyo Company Limited
8.13 Bayer AG
8.14 GlaxoSmithKline
8.15 Merck & Co., Inc.
8.16 Johnson & Johnson
8.17 Biogen, Inc.
8.18 Shire
8.19 Amgen, Inc.
8.20 Deciphera
8.21 Atara Biotherapeutics
8.22 ProQR

9 DEVELOPMENT TREND OF ANALYSIS OF RARE DISEASE DRUG MARKET

9.1 Global Rare Disease Drug Market Trend Analysis
  9.1.1 Global 2018-2025 Rare Disease Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Rare Disease Drug Sales Price Forecast
9.2 Rare Disease Drug Regional Market Trend
  9.2.1 North America 2018-2025 Rare Disease Drug Consumption Forecast
  9.2.2 Europe 2018-2025 Rare Disease Drug Consumption Forecast
  9.2.3 China 2018-2025 Rare Disease Drug Consumption Forecast
  9.2.4 Japan 2018-2025 Rare Disease Drug Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Rare Disease Drug Consumption Forecast
  9.2.6 India 2018-2025 Rare Disease Drug Consumption Forecast
9.3 Rare Disease Drug Market Trend (Product Type)
9.4 Rare Disease Drug Market Trend (Application)

10 RARE DISEASE DRUG MARKETING TYPE ANALYSIS

10.1 Rare Disease Drug Regional Marketing Type Analysis
10.2 Rare Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Rare Disease Drug by Region
10.4 Rare Disease Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RARE DISEASE DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RARE DISEASE DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rare Disease Drug
Table Product Specifications of Rare Disease Drug
Table Classification of Rare Disease Drug
Figure Global Production Market Share of Rare Disease Drug by Type in 2017
Figure >1‰ Picture
Table Major Manufacturers of >1‰
Figure 0.65‰～1‰ Picture
Table Major Manufacturers of 0.65‰～1‰
Figure <0.1‰ Picture
Table Major Manufacturers of <0.1‰
Table Applications of Rare Disease Drug
Figure Global Consumption Volume Market Share of Rare Disease Drug by Application in 2017
Figure Hospital Pharmacies Examples
Table Major Consumers in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Major Consumers in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Major Consumers in Retail pharmacies
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Rare Disease Drug by Regions
Figure North America Rare Disease Drug Market Size (Million USD) (2013-2025)
Figure Europe Rare Disease Drug Market Size (Million USD) (2013-2025)
Figure China Rare Disease Drug Market Size (Million USD) (2013-2025)
Figure Japan Rare Disease Drug Market Size (Million USD) (2013-2025)
Figure Southeast Asia Rare Disease Drug Market Size (Million USD) (2013-2025)
Figure India Rare Disease Drug Market Size (Million USD) (2013-2025)
Table Rare Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Rare Disease Drug in 2017
Figure Manufacturing Process Analysis of Rare Disease Drug
Figure Industry Chain Structure of Rare Disease Drug
Table Capacity and Commercial Production Date of Global Rare Disease Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Rare Disease Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Rare Disease Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Rare Disease Drug Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Rare Disease Drug 2013-2018E
Figure Global 2013-2018E Rare Disease Drug Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Rare Disease Drug Market Size (Value) and Growth Rate
Table 2013-2018E Global Rare Disease Drug Capacity and Growth Rate
Table 2017 Global Rare Disease Drug Capacity (K Doses) List (Company Segment)
Table 2013-2018E Global Rare Disease Drug Sales (K Doses) and Growth Rate
Table 2017 Global Rare Disease Drug Sales (K Doses) List (Company Segment)
Table 2013-2018E Global Rare Disease Drug Sales Price (USD/Dose)
Table 2017 Global Rare Disease Drug Sales Price (USD/Dose) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure North America 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure North America 2017 Rare Disease Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure Europe 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure Europe 2017 Rare Disease Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure China 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure China 2017 Rare Disease Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure Japan 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure Japan 2017 Rare Disease Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure Southeast Asia 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure Southeast Asia 2017 Rare Disease Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Doses) of Rare Disease Drug 2013-2018E
Figure India 2013-2018E Rare Disease Drug Sales Price (USD/Dose)
Figure India 2017 Rare Disease Drug Sales Market Share
Table Global 2013-2018E Rare Disease Drug Sales (K Doses) by Type
Table Different Types Rare Disease Drug Product Interview Price
Table Global 2013-2018E Rare Disease Drug Sales (K Doses) by Application
Table Different Application Rare Disease Drug Product Interview Price
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2017 Novartis AG Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Novartis AG Rare Disease Drug Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bristol-Myers Squibb Company Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Bristol-Myers Squibb Company Rare Disease Drug Business Region Distribution
Table Celgene Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2015 Celgene Corporation Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Celgene Corporation Rare Disease Drug Business Region Distribution
Table F. Hoffmann-La Roche Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2017 F. Hoffmann-La Roche Ltd. Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 F. Hoffmann-La Roche Ltd. Rare Disease Drug Business Region Distribution
Table Pfizer, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Pfizer, Inc. Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Pfizer, Inc. Rare Disease Drug Business Region Distribution
Table Sanofi S.A. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Sanofi S.A. Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Sanofi S.A. Rare Disease Drug Business Region Distribution
Table Alexion Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Alexion Pharmaceuticals, Inc. Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Alexion Pharmaceuticals, Inc. Rare Disease Drug Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2017 Eli Lilly and Company Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Eli Lilly and Company Rare Disease Drug Business Region Distribution
Table Novo Nordisk A/S Information List
Table Product A Overview
Table Product B Overview
Table 2017 Novo Nordisk A/S Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Novo Nordisk A/S Rare Disease Drug Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2017 AstraZeneca Rare Disease Drug Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 AstraZeneca Rare Disease Drug Business Region Distribution
Table Eisai Co., Ltd. Information List
Table Daiichi Sankyo Company Limited Information List
Table Bayer AG Information List
Table GlaxoSmithKline Information List
Table Merck & Co., Inc. Information List
Table Johnson & Johnson Information List
Table Biogen, Inc. Information List
Table Shire Information List
Table Amgen, Inc. Information List
Table Deciphera Information List
Table Atara Biotherapeutics Information List
Table ProQR Information List
Figure Global 2018-2025 Rare Disease Drug Market Size (K Doses) and Growth Rate Forecast
Figure Global 2018-2025 Rare Disease Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Rare Disease Drug Sales Price (USD/Dose) Forecast
Figure North America 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Figure China 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Figure Europe 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Figure Japan 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Figure India 2018-2025 Rare Disease Drug Consumption Volume (K Doses) and Growth Rate Forecast
Table Global Sales Volume (K Doses) of Rare Disease Drug by Type 2018-2025
Table Global Consumption Volume (K Doses) of Rare Disease Drug by Application 2018-2025
Table Traders or Distributors with Contact Information of Rare Disease Drug by Region